News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard May 20, 2022 StatementGlobal healthCOVID-19 Novavax Files in the European Union for Expanded Conditional Marketing Authorization of COVID-19 Vaccine as a Booster in Individuals Aged 18 and Over Download May 13, 2022 StatementCOVID-19 Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan Download May 9, 2022 Press releaseCorporate and finance Novavax Reports First Quarter 2022 Financial Results and Operational Highlights Download May 6, 2022 StatementCOVID-19 Novavax Submits Variations to Expand Australian and New Zealand Provisional Approval of Nuvaxovid™ COVID-19 Vaccine to Adolescents aged 12 Through 17 Years Download May 6, 2022 StatementCOVID-19 Novavax’ COVID-19 Vaccine Nuvaxovid™ Arrives in Singapore Download May 4, 2022 Statement Novavax Requests Expanded Authorization of Nuvaxovid™ COVID-19 Vaccine to Adolescents Aged 12 through 17 Years in Great Britain* Download May 4, 2022 Novavax to Participate in BofA Securities 2022 Healthcare Conference Download May 2, 2022 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022 Download Apr 29, 2022 COVID-19 FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine Download Apr 22, 2022 COVID-19 Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial Download Apr 20, 2022 COVID-19 Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Download Apr 19, 2022 COVID-19 Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan Download Apr 18, 2022 COVID-19 Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases Download Apr 13, 2022 COVID-19 Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine Download Apr 8, 2022 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand Download Mar 31, 2022 Press release Novavax Statement on Arrival of its COVID-19 Vaccine in Canada Download Mar 31, 2022 COVID-19 Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) Download Mar 25, 2022 COVID-19 Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine Download Mar 22, 2022 COVID-19 Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India Download Mar 10, 2022 Novavax Announces Launch of Global Vaccine Education Programs Download Mar 2, 2022 Novavax to Participate in Cowen's 42nd Annual Health Care Conference Download Feb 28, 2022 Corporate and finance Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Download Feb 28, 2022 COVID-19 Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial Download Feb 23, 2022 COVID-19 Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States Download Feb 21, 2022 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022 Download Show 5102550100 per page«123456789…15»